Tonghua Dongbao Pharmaceutical

• Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

  Phase 3, Completed, 550 people, 15 Dec 2025

• A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes

  Phase 3, Status unknown, 510 people, 19 Aug 2024

• A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects

  Phase 1, Status unknown, 44 people, 10 Jun 2024

• NCT05373199

  Collaborator, Phase 1, Completed, 30 people, 13 May 2022

• NCT05373186

  Collaborator, Phase 1, Completed, 27 people, 13 May 2022

Sources: clinicaltrials.gov

• Collaboration

  6 Mar 2021

• Adocia

  Licence, 27 Apr 2018

Sources: static.cninfo.com.cn